Breaking news from The Wall Street Journal.
News Alert | Alzheimer’s Drug Slows Disease Progression in Trial |
|
| Eisai and Biogen said their experimental Alzheimer’s drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects for approval. |
| | Read WSJ's latest headlines › | |
|
|